NCT02650427View on ClinicalTrials.gov

A Pilot Study to Evaluate the Safety of a 3 Weeks Sitagliptin Treatment in HCC Patients Undergoing Liver Resection

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

February 29, 2016

Primary Completion Date

September 30, 2018

Study Completion Date

September 30, 2018

Conditions

Hepato Carcinoma

Interventions

DRUG

Sitagliptin

100mg or 200mg or 600mg, daily for 3 weeks ± 7 days

Trial Locations (1)

75013

Pitié-Salpêtrière Hospital, Paris

All Listed Sponsors

lead

Institut National de la Santé Et de la Recherche Médicale, France

OTHER_GOV

NCT02650427 - A Pilot Study to Evaluate the Safety of a 3 Weeks Sitagliptin Treatment in HCC Patients Undergoing Liver Resection | Biotech Hunter | Biotech Hunter